Genitourinary Cancer
Conference Coverage
Gene therapy appears effective in bladder cancer patients with few options
SAN FRANCISCO – Intravesical gene therapy produced durable responses in patients with non–muscle invasive bladder cancer that did not respond to...
Conference Coverage
Seminoma: Risk-adapted strategy could mean less toxic chemo
SAN FRANCISCO – Findings of the SEMITEP trial suggest that early FDG-PET identifies the two-thirds of men with highly chemosensitive low-volume...
News
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumors
Two-thirds of patients with advanced renal cell carcinoma had a clinical response to the TKI/immune checkpoint inhibitor combination.
News
New nomogram better predicts bladder cancer risk
In a retrospective analysis of patients who underwent a full microhematuria evaluation, patients with bladder cancer had a higher amount of...
Conference Coverage
Combo shows promise for checkpoint inhibitor-refractory urothelial carcinoma
NATIONAL HARBOR, MD – Combination sitravatinib and nivolumab produced responses in patients with checkpoint...
News
FDA approves darolutamide for nonmetastatic CRPC
The approval was based on improved metastasis free survival in the randomized ARAMIS trial of 1,509 patients with nonmetastatic, castration-...
Article
Testicular Cancer: Diagnosis and Treatment
News
Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancer
Sperm count and concentration remained stable or increased in patients with clinical stage I testicular cancer who underwent unilateral...
Conference Coverage
First-line avelumab/axitinib for RCC benefits wide range of patients
SAN FRANCISCO – Subgroup analyses of the JAVELIN Renal 101 trial show that first-line avelumab/axitinib yields better PFS and ORRs than sunitinib...
News
Obesity-related cancers increasing in younger adults
Half of obesity-related cancers have increased in incidence among younger adults over the past two decades.
